Free Trial
LON:POLB

Poolbeg Pharma (POLB) Share Price, News & Analysis

Poolbeg Pharma logo
GBX 3.08 +0.08 (+2.67%)
As of 11:58 AM Eastern

About Poolbeg Pharma Stock (LON:POLB)

Key Stats

Today's Range
3
3.20
50-Day Range
2.40
3.78
52-Week Range
2.25
13.30
Volume
1.41 million shs
Average Volume
2.29 million shs
Market Capitalization
£15.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive POLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter.

POLB Stock News Headlines

Poolbeg Pharma (LON:POLB) Trading Down 1.6% - Time to Sell?
Miss This Window And You Miss Everything
There’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.
See More Headlines

POLB Stock Analysis - Frequently Asked Questions

Poolbeg Pharma's stock was trading at GBX 7.10 at the beginning of the year. Since then, POLB shares have decreased by 56.6% and is now trading at GBX 3.08.

Poolbeg Pharma PLC (LON:POLB) released its earnings results on Tuesday, May, 20th. The company reported ($1.16) earnings per share for the quarter.

Shares of POLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Poolbeg Pharma investors own include EQTEC (EQT), Great Western Mining (GWMO), Power Metal Resources (POW), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), Alzamend Neuro (ALZN) and Alpine 4 (ALPP).

Company Calendar

Last Earnings
5/20/2025
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:POLB
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (851.82)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£4.50 billion
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.56%
Return on Assets
-21.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.61
Quick Ratio
47.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 1.46 per share
Price / Cash Flow
2.11
Book Value
GBX 2,489.80 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
513,958,333
Free Float
N/A
Market Cap
£15.83 million
Optionable
Not Optionable
Beta
2.11
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:POLB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners